Table 4 Characteristics of subjects and tissue BPA concentrations in cases and controls.

From: Bisphenol-A in biological samples of breast cancer mastectomy and mammoplasty patients and correlation with levels measured in urine and tissue

Characteristic

Number

Concentration of BPA in breast adipose tissue, Mean ± SD (ng/g tissue)

Cases

N = 41 

Controls

N = 11

P value

Cases

Controls

P value

Samples with detectable BPA; N (%)

30 (73.17)

6 (54.54)

 

4.20 ± 2.40

1.80 ± 1.05

0.008**

Age group (y); Mean ± SD

      

Among all samples

52.68 ± 9.1

48.18 ± 4.62

    

Among samples with detectable BPA

51.37 ± 9

47.17 ± 6.11

    

30–49; N (%)

14 (46.67)

4 (66.67)

 

4.95 ± 2.30

1.50 ± 1.05

 

50–59; N (%)

10 (33.33)

2 (33.33)

 

4.20 ± 2.60

2.40 ± 0.95

0.98

60–69; N (%)

4 (13.33)

 

2.85 ± 1.40

 

69–79; N (%)

2 (6.67)

 

1.60 ± 1.20

 

BMI (Kg/m2); Mean ± SD

      

Among all samples

26.55 ± 2.82

25.91 ± 3.27

    

Among samples with detectable BPA

26.93 ± 3.05

26.91 ± 4.16

    

Recommended weight (18.5–25); N (%)

9 (30)

3 (50)

 

4.45 ± 2.65

1.55 ± 1.40

 

Overweight (25–30); N (%)

17 (56.67)

2 (33.33)

 

3.75 ± 2.30

2.30 ± 0.85

0.48

Obese (30–35); N (%)

4 (13.33)

1 (16.66)

 

5.60 ± 2.25

1.55 ± 0

 
  1. ** P < 0.01; comparison tissue BPA concentrations between cases and controls.